BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22020924)

  • 1. COX inhibitors directly alter gene expression: role in cancer prevention?
    Wang X; Baek SJ; Eling T
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):641-57. PubMed ID: 22020924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drugs and melanoma.
    Sanz-Motilva V; Martorell-Calatayud A; Nagore E
    Curr Pharm Des; 2012; 18(26):3966-78. PubMed ID: 22632752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in gene expression contribute to cancer prevention by COX inhibitors.
    Baek SJ; Eling TE
    Prog Lipid Res; 2006 Jan; 45(1):1-16. PubMed ID: 16337272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.
    Baek SJ; Kim KS; Nixon JB; Wilson LC; Eling TE
    Mol Pharmacol; 2001 Apr; 59(4):901-8. PubMed ID: 11259636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer.
    Raz A
    Biochem Pharmacol; 2002 Feb; 63(3):343-7. PubMed ID: 11853685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene.
    Baek SJ; Wilson LC; Lee CH; Eling TE
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1126-31. PubMed ID: 12023546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
    Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
    Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAIDs inhibit tumorigenesis, but how?
    Gurpinar E; Grizzle WE; Piazza GA
    Clin Cancer Res; 2014 Mar; 20(5):1104-13. PubMed ID: 24311630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene.
    Kim JH; Chang JH; Rhee KH; Yoon JH; Kwon SH; Song K; Lee KW; Cho CI; Jeon JH; Kim KS
    Int J Cancer; 2008 Apr; 122(8):1765-73. PubMed ID: 18076062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non Steroidal Anti Inflammatory Drugs As Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition.
    Guarnieri T
    Curr Cancer Drug Targets; 2016; 16(2):186-97. PubMed ID: 26310524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis.
    Jang TJ; Kang HJ; Kim JR; Yang CH
    Carcinogenesis; 2004 Oct; 25(10):1853-8. PubMed ID: 15180942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
    Shureiqi I; Chen D; Lee JJ; Yang P; Newman RA; Brenner DE; Lotan R; Fischer SM; Lippman SM
    J Natl Cancer Inst; 2000 Jul; 92(14):1136-42. PubMed ID: 10904086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
    Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
    Taketo MM
    J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
    Jiménez P; García A; Santander S; Piazuelo E
    Curr Pharm Des; 2007; 13(22):2261-73. PubMed ID: 17691999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proapoptotic anti-inflammatory drugs.
    Myers C; Koki A; Pamukcu R; Wechter W; Padley RJ
    Urology; 2001 Apr; 57(4 Suppl 1):73-6. PubMed ID: 11295599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targets.
    Liggett JL; Zhang X; Eling TE; Baek SJ
    Cancer Lett; 2014 May; 346(2):217-24. PubMed ID: 24486220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2: a novel target for cancer chemotherapy?
    Dempke W; Rie C; Grothey A; Schmoll HJ
    J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.